Search Within

Matthew David Hellmann

  1. "Body Imaging Service"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (23)
Groups
  1. Body Imaging Service (63)
  2. Department of Medicine (63)
  3. Radiology, Department of (63)
  4. Solid Tumor Oncology Division (63)
  5. Thoracic Oncology (63)
  6. Weinberg Fellows (38)

More Groups

People
  1. Andrew Plodkowski (47)
  2. Hira Rizvi (47)
  3. Kathryn Arbour (25)
  4. Mark Kris (25)
  5. Gregory Riely (20)
  6. Charles Rudin (19)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (9)
  5. 2020 (11)
  6. 2019 (10)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Journal of Thoracic Oncology (9)
  3. Annals of Oncology (8)
  4. Clinical Cancer Research (5)
  5. Cancer Discovery (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (11)
  3. American Association for Cancer Research (10)
  4. Oxford University Press (9)
  5. Cell Press (3)
  6. Nature Publishing Group (3)

More Publishers

Results (63)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K.; Lin, J.; Vajdi, A.; Tolstorukov, M.; Hong, L.; Zhang, J.; Vokes, N.; Li, Y.; Spurr, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade
    Journal Article

    Arbour, K. C.; Luu, A. T.; Luo, J.; Rizvi, H.; Plodkowski, A. J.; Sakhi, M.; Huang, K. B.; Digumarthy, S. R.; Ginsberg, M. S.; Girshman, J.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vokes, N.; Hoojghan, A. V.; Li, Y. Y.; Cherniack, A. D.; Recondo, G.; Lamberti, G.; Venkatraman, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Acquired resistance to PD-1 blockade in NSCLC
    Meeting Abstract

    Schoenfeld, A. J.; Rizvi, H.; Memon, D.; Luo, J.; Preeshagul, I. R.; Sauter, J. L.; Plodkowski, A. J.; Vanderbilt, C.; Miller, M. L.; Hellmann, M. D.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Hui, A. B.; Chabon, J. J.; Moding, E. J.; Lebow, E. S.; Araujo, J. A.; Isbell, J. M.; Jones, D. R.; Ginsberg, M. S.; Myers, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Luo, J.; Bandlamudi, C.; Ricciuti, B.; Vokes, N.; Schoenfeld, A. J.; Egger, J. V.; Sauter, J. L.; Plodkowski, A. J.; Preeshagul, I. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small-cell lung cancer and a poor performance status
    Meeting Abstract

    Alessi, J. V. M.; Ricciuti, B.; Aguilar, E. J.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save